SecBot SecBot

RCEL

AVITA Medical, Inc.
OTC· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001762303 Healthcare & Medical Devices
$15.51 +0.09 (+0.58%)
Oct 23 4:00 PM ET · prev $15.42
Market cap
$476.9M
Small cap
Consensus
Buy
80% Buy or better · 10 analysts
Median target
🔒 Subscribers only
1 year
+290.7%
from $3.97 · Oct 24
30 days
+33.9%
from $11.58
52-week range
$3.27–15.51
at the high
Avg volume 20D
387.4K
shares / day
Short interest
2.89M
≈9.3% of shares · +0.1%
Days to cover
9.2
at average volume
Insider net
+$234.6K
2 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
6
analyzed by SecBot
SecBot read MIXED 3 reports · 90 days
Balance 0 bearish · 0 bullish · 1 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 1/3 ·Next Earnings date, Nov 5, 2026
Strongest MIXED In Q2 2026, institutional activity in AVITA Medical (RCEL) was mixed: 14 buyers added $2.2M in new holdings…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $234.6K at an average $4.19. No open-market sales. Price is 270% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 14 added (0 new), 9 trimmed or exited.

  • AnalystsBULLISH

    8 of 10 rate it Buy or better.

  • Short sellersSTEADY

    Short interest +0.1% to 2.89M shares. 9.2 days to cover, ≈9.3% of shares.

  • TrendUPTREND

    35% above its 50-day average. New closing high $15.51 on Oct 23.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.TRIM564,952$2.3M
GEODE CAPITAL MANAGEMENT, LLCTRIM339,822$1.4M
MARSHALL WACE, LLPDOUBLED338,387$1.4M
MORGAN STANLEYADD200,462$827.9K
NewEdge Advisors, LLCADD148,931$615.1K
MACQUARIE GROUP LTDDOUBLED144,164$595.4K
STATE STREET CORPTRIM128,977$532.7K
Quantinno Capital Management LPDOUBLED105,248$434.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

10 analysts
Buy 80% rate it Buy or better
Strong Buy3Buy5Hold1Sell0Strong Sell1

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Oct 12, 2026BTIG
MAINTAIN
MAINTAINBuy
Aug 28, 2026Lake Street
MAINTAIN
MAINTAINBuy
Aug 19, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Aug 19, 2026BTIG
MAINTAIN
MAINTAINBuy
Aug 7, 2026BTIG
UPGRADE
UPGRADEBuy
May 15, 2026Lake Street
UPGRADE
UPGRADEBuy

Insider ledger

Form 4
$234.6K
bought · 2 insiders
$0
sold · 0 insiders
+270.3%
vs their $4.19 cost
DateInsiderTypeValue
Jun 12, 2026
O'Toole David D
CFO
BUY$7.9K
Jun 9, 2026
Woody Joseph Fralin
Director
BUY$21.0K
Jun 9, 2026
Woody Joseph Fralin
Director
BUY$20.8K
Jun 9, 2026
Woody Joseph Fralin
Director
BUY$20.9K
Jun 3, 2026
Woody Joseph Fralin
Director
BUY$20.5K
Jun 3, 2026
Woody Joseph Fralin
Director
BUY$20.4K
Jun 2, 2026
Woody Joseph Fralin
Director
BUY$20.9K
Jun 2, 2026
Woody Joseph Fralin
Director
BUY$21.0K

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
2,887,981
shares short
+0.1%
vs prior settlement
9.2
days to cover
≈9.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 20, 2026 SEC
AVITA Medical announced it will report its Q3 2026 results on November 5, 2026.
PRESS-RELEASE — Impact 1/10
Oct 20, 2026 Earnings
AVITA Medical to Announce Third Quarter 2026 Financial Results
AVITA Medical to report its third quarter 2026 financial results on Thursday November 5, 2026...
Sep 22, 2026 SEC
In Q2 2026, institutional activity in AVITA Medical (RCEL) was mixed: 14 buyers added $2.2M in new holdings, while 9…
INST-CLUSTER — Impact 3/10
Aug 9, 2026 SEC
AVITA Medical announced it will host a conference call on August 12, 2026 to discuss its Q2 2026 results.
PRESS-RELEASE — Impact 1/10
Jun 30, 2026 Inst.
BlackRock, Inc. — TRIM
564,952 shares ($2.3M)
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
339,822 shares ($1.4M)
Jun 12, 2026 Insider
O'Toole David D bought 2,000 shares
CFO @ $3.97 ($7.9K)
Jun 9, 2026 Insider
Woody Joseph Fralin bought 5,000 shares
Director @ $4.20 ($21.0K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
🔒 Fresh data — subscribers only
Recent
Oct 20, 2026
Earnings
AVITA Medical to Announce Third Quarter 2026 Financial Results
AVITA Medical to report its third quarter 2026 financial results on Thursday November 5, 2026...
Aug 9, 2026
Earnings
AVITA Medical to Host Investor Webinar Briefing
AVITA to host Q2 2026 investor webinar on August 12
Aug 7, 2026
Company news
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
AVITA Medical will present at Canaccord Genuity's 46th Annual Growth Conference, with CEO Cary Vance speaking Aug. 12; webcast available online.
Aug 6, 2026
Earnings
AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven
AVITA Medical reported record Q2 revenue of $21.7M (+18%), raised 2026 guidance to $86–89M, and expects to achieve cash flow breakeven in Q4 2026.
Aug 6, 2026
Earnings date
RCEL Q2 2026 Earnings Scheduled — 2026-08-06

SecBot reports

6 filings · 2 press releases · 0 bullish · 1 bearish · 1 mixed · 4 neutral
All RCEL filing & press-release reports (8)